RxDoctor Payments DataLook up a doctor →

John Stein, MD

Family Medicine · Chesterfield, MONPI 1629143219

Payments from drug & device makers

$29,441in general payments, 2019–2025

Across 714 payments — averaging $41.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$17K
  • Esperion Therapeutics, Inc.$3K
  • AbbVie$2K
  • Novo Nordisk$829
  • Lilly USA, LLC$768
  • AstraZeneca$573
  • plus $5K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)65$16,784
Esperion Therapeutics, Inc.36$3,449
AbbVie(2 entities)157$1,684
Novo Nordisk46$829
Lilly USA, LLC37$768
AstraZeneca23$573
Takeda Pharmaceuticals U.S.A., Inc.31$519
Amarin Pharma, Inc.37$420
Neos Therapeutics, LP20$360
Otsuka America Pharmaceutical, Inc.30$341
Axsome Therapeutics, Inc.12$282
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)18$211
Novartis12$198
Tris Pharma Inc11$192
Astellas Pharma US Inc7$191
Vanda Pharmaceuticals Inc.16$187
Corium, LLC16$181
Kowa Pharmaceuticals America, Inc.20$176
Noven Therapeutics, LLC14$135
Bayer6$120
Noven Pharmaceuticals, Inc.2$117
Supernus Pharmaceuticals, Inc.6$115
Ironshore Pharmaceuticals Inc.6$110
Rhythm Pharmaceuticals, Inc.1$108
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$105
Merck5$86
Sunovion Pharmaceuticals Inc.7$76
Eisai Inc.4$76
Antares Pharma, Inc.1$75
GSK5$74
Sanofi-aventis U.S. LLC4$69
Bausch Health US, LLC4$67
Adlon Therapeutics L.p.4$66
Azurity Pharmaceuticals, Inc.4$63
Lundbeck LLC2$58
Avanir Pharmaceuticals, Inc.3$54
Jazz Pharmaceuticals Inc.3$49
Regeneron Healthcare Solutions, Inc.3$47
Pfizer3$44
Cleerly, Inc.2$37
Almatica Pharma LLC2$35
Phathom Pharmaceuticals, Inc.2$29
Abbott2$28
Johnson & Johnson2$27
Radius Health, Inc.2$26
Nevro Corp.1$22
Shire North American Group Inc1$20
Itamar Medical Inc1$18
Collegium Pharmaceutical, Inc.1$17
Genentech USA, Inc.1$17
Biohaven Pharmaceuticals, Inc.1$16
GE HealthCare1$16
Exact Sciences1$15
Optos, Inc.1$15
Boehringer Ingelheim1$13
Neuronetics, Inc.1$13
Arbor Pharmaceuticals, Inc.1$13
Travere Therapeutics, Inc.2$7

How this compares

$29,441 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$33,312
Medicare patients
103
Services billed
476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Chesterfield

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →